Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis
Andreas Kerschbaumer, Josef S Smolen, Ricardo J O Ferreira, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 6, pp. 760-774
Open Access | Times Cited: 16

Showing 16 citing articles:

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update
Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 6, pp. 706-719
Open Access | Times Cited: 62
Methotrexate continuation increases fracture risk in patients who sustained lower limb insufficiency fractures
Barbara Hauser, Andrew T Merriman, Jonathan Foley, et al.
Annals of the Rheumatic Diseases (2025)
Closed Access | Times Cited: 1
Precision medicine using molecular-target drugs in psoriatic arthritis
Ippei Miyagawa, Yoshiya Tanaka
Therapeutic Advances in Musculoskeletal Disease (2025) Vol. 17
Open Access
Deciphering the role of cytokines in aging: biomarker potential and effective targeting
Panagiotis Poulios, Stamoulis Skampouras, Christina Piperi
Mechanisms of Ageing and Development (2025) Vol. 224, pp. 112036-112036
Closed Access
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry
Giuseppe Lopalco, Maria Concetta Morrone, Fabiola Atzeni, et al.
Therapeutic Advances in Musculoskeletal Disease (2025) Vol. 17
Open Access
Imaging in clinical trials for psoriatic arthritis: a scoping review
Andrew Xiao, A Roy, Liz Dennett, et al.
Skeletal Radiology (2025)
Closed Access
Bimekizumab in the Treatment of Axial Spondyloarthritis and Psoriatic Arthritis: A New Kid on the Block
Julie Sarrand, Laurie Baglione, Charlotte Bouvy, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2315-2315
Open Access
Diagnostic algorithm for axial involvement in psoriatic arthritis
Е. Е. Gubar, Т. В. Коротаева, L. D. Vorobyeva, et al.
Rheumatology Science and Practice (2025) Vol. 63, Iss. 1, pp. 79-85
Open Access
The Expanding Therapeutic Potential of Deucravacitinib Beyond Psoriasis: A Narrative Review
Chul Hwan Bang, Chul Jong Park, Yoon‐Seob Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1745-1745
Open Access
Unmet needs in psoriatic arthritis, a narrative review
Clementina López‐Medina, Umut Kalyoncu, Laure Gossec
Archives of Rheumatology (2024) Vol. 39, Iss. 2, pp. 159-171
Open Access | Times Cited: 3
Greetings from the editor 2024/2
Josef S Smolen
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 6, pp. 685-686
Open Access | Times Cited: 1
The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis
Francesco Caso, Mauro Fatica, Mario Ferraioli, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 8, pp. 719-731
Closed Access | Times Cited: 1
A Case Series Report on the Effect of Tofacitinib on Joint Inflammation and Gut Microbiota Composition in Psoriatic Arthritis Patients Naive to Biologic Agents
Andrea Picchianti Diamanti, Concetta Panebianco, Valeria Di Gioia, et al.
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2387-2387
Open Access
Is Total Joint Arthroplasty an Effective and Safe Option for Psoriatic Arthritis Patients? A Scoping Review
Jacopo Ciaffi, Lorenzo Bianchi, Alberto Di Martino, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5552-5552
Open Access
Updated international recommendations (EULAR, 2023) for the treatment of psoriatic arthritis
Yu. L. Kоrsakova, Т. В. Коротаева, Ш. Ф. Эрдес, et al.
Rheumatology Science and Practice (2024) Vol. 62, Iss. 5, pp. 474-483
Open Access
Ixekizumab in the treatment of psoriatic arthritis
Yu. L. Kоrsakova, Т. В. Коротаева
Rheumatology Science and Practice (2024) Vol. 62, Iss. 6, pp. 590-597
Open Access
Page 1

Scroll to top